MeiraGTx Holdings (MGTX) Return on Capital Employed (2018 - 2025)
MeiraGTx Holdings (MGTX) posted Return on Capital Employed of 49.19% for Q4 2025, up 87.04% on a QoQ basis from 379.67% in Q3 2025, and up 939.0% year-over-year from 4.73% in Q4 2024.
MeiraGTx Holdings (MGTX) Return on Capital Employed (2018 - 2025) Analysis & Trends
MeiraGTx Holdings' Return on Capital Employed history runs 8 years deep, the most recent figure standing at 49.19% for Q4 2025.
- Quarterly Return on Capital Employed rose 939.0% year-over-year to 49.19% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 49.19% (up 939.0% YoY) and the FY2025 annual result came in at 44.47%, up 1076.0% from the prior year.
- Return on Capital Employed was 49.19% for Q4 2025 at MeiraGTx Holdings, up from 379.67% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 180.22% in Q2 2023 and bottomed at 379.67% in Q3 2025.
- A 5-year average of 32.3% and a median of 52.71% in 2024 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2024 — Return on Capital Employed soared 13242 bps — and 2025, when it tumbled 32358 bps.
- MeiraGTx Holdings' Return on Capital Employed stood at 77.43% in 2021, then plunged by 86 bps to 143.92% in 2022, then soared by 75 bps to 36.55% in 2023, then tumbled by 60 bps to 58.58% in 2024, then gained by 16 bps to 49.19% in 2025.
- Business Quant data shows MGTX's Return on Capital Employed at 49.19% in Q4 2025, 379.67% in Q3 2025, and 94.72% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -31.80% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.46% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -68.47% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 21.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 10.19% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -68.84% |
| 10 | MeiraGTx Holdings | 973.21 Mn | 907.27 Mn | - | -49.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -49.19% |
| Sep 30, 2025 | -379.67% |
| Jun 30, 2025 | -94.72% |
| Mar 31, 2025 | -81.96% |
| Dec 31, 2024 | -58.58% |
| Sep 30, 2024 | -56.09% |
| Jun 30, 2024 | -49.34% |
| Mar 31, 2024 | -36.62% |
| Dec 31, 2023 | -36.55% |
| Sep 30, 2023 | -188.51% |
| Jun 30, 2023 | 180.22% |
| Mar 31, 2023 | -149.98% |
| Dec 31, 2022 | -143.92% |
| Sep 30, 2022 | 128.03% |
| Jun 30, 2022 | 139.10% |
| Mar 31, 2022 | -80.37% |
| Dec 31, 2021 | -77.43% |
| Sep 30, 2021 | 139.73% |
| Jun 30, 2021 | 117.07% |
| Mar 31, 2021 | 132.87% |